Product Information

OMEPRAZOLE-BICARB 40-1,680 PKT is a generic product labeled by Strides Pharma Inc., priced at $8.3328 per EA under NDC 64380018302. Its NADAC has been published 140 times since Dec 20, 2023.

FDA first approved this application on Apr 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the omeprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OMEPRAZOLE-BICARB 40-1,680 PKT

omeprazole
$8.3328per EA
High Outlier

Strength

40; 1680 mg/1720mg; mg/1720mg

NDC

64380018302

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA079182

FDA Approved

4/19/2013

TE Code

AB

On Market Since

10/1/2022

Pharmacological Classes

Alkalinizing Activity
Cytochrome P450 2C19 Inhibitors
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has been published 140 times since Dec 20, 2023, and over the history we have for it it has declined 36.8%. The table below summarizes its recorded NADAC range and movement.

Current price$8.3328 per EA
All-time high$18.3077 (Jun 12, 2024)
All-time low$8.3328 (Aug 19, 2026)
52-week high$10.2732
52-week low$8.3328
Median price$11.5646
Average price$11.8118
Largest weekly change+18.7% (Apr 17, 2024)
Weeks tracked140
Tracking sinceDec 20, 2023

Price History

1W

-8.2%

1M

-8.2%

3M

-12.6%

6M

-9.8%

1Y

-16.6%

3Y

N/A

5Y

N/A

All

-36.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the omeprazole market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OMEPRAZOLE-BICARB 40-1,680 PKT?

The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE-BICARB 40-1,680 PKT, manufactured by Strides Pharma Inc., is $8.3328 per EA (NDC 64380018302), effective Aug 19, 2026.

How has the price of OMEPRAZOLE-BICARB 40-1,680 PKT changed over time?

Over the history we have for it, the NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has declined 36.8%. It has been tracked across 140 weekly CMS publications since Dec 20, 2023.

What are the highest and lowest recorded NADAC prices for OMEPRAZOLE-BICARB 40-1,680 PKT?

Since Dec 20, 2023, the NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has ranged from a low of $8.3328 (Aug 19, 2026) to a high of $18.3077 (Jun 12, 2024), with a median of $11.5646 per EA.

Are there cheaper alternatives to OMEPRAZOLE-BICARB 40-1,680 PKT?

No other NADAC-published product currently shares the active ingredient and strength of OMEPRAZOLE-BICARB 40-1,680 PKT in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OMEPRAZOLE-BICARB 40-1,680 PKT?

OMEPRAZOLE-BICARB 40-1,680 PKT (NDC 64380018302) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.